Staar Surgical (STAA) reported $44.32 million in revenue for the quarter ended June 2025, representing a year-over-year decline of 55.2%. EPS of -$0.07 for the same period compares to $0.33 a year ago.
The reported revenue represents a surprise of +6.63% over the Zacks Consensus Estimate of $41.56 million. With the consensus EPS estimate being -$0.56, the EPS surprise was +87.5%.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how Staar Surgical performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Net Geographic Sales- United States: $5.64 million compared to the $6.46 million average estimate based on two analysts. The reported number represents a change of +4.4% year over year.
- Net Geographic Sales- Other International: $18.18 million compared to the $24.03 million average estimate based on two analysts. The reported number represents a change of -10.6% year over year.
- Net Geographic Sales- Japan: $10.92 million compared to the $10.08 million average estimate based on two analysts. The reported number represents a change of +10.4% year over year.
- Net Geographic Sales- China: $5.3 million compared to the $0.96 million average estimate based on two analysts. The reported number represents a change of -91.6% year over year.
View all Key Company Metrics for Staar Surgical here>>>
Shares of Staar Surgical have returned +59.8% over the past month versus the Zacks S&P 500 composite's +0.5% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
STAAR Surgical Company (STAA): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
